Berlin, Germany
Ada Health, founded in 2011 and headquartered in Germany, is a noteworthy player in the AI, Digital Health, and Health Care industries. Its mission, captured by the slogan, "Help us improve human health across the globe: #joinAda," underscores its commitment to enhancing health outcomes worldwide.
The company has developed the world's most popular symptom assessment app, boasting 13 million users and 32 million completed assessments. Impressively, every three seconds, an individual seeks personal health guidance from Ada. Beyond its consumer-facing app, Ada Health offers robust enterprise solutions that assist a wide range of stakeholders, from healthcare systems to governments, in making informed health decisions and optimizing resource utilization.
In terms of financial backing, Ada Health secured a $30.00M Series B investment in February 2022, with involvement from notable investors Leaps by Bayer and Vitruvian Partners. This investment reflects strong confidence in Ada's innovative approach to improving global health.
